Why China's vaccines are gaining international momentum


BEIJING (CGTN): There has been much news of late concerning Covid-19 vaccine progress from the two big American pharmacy firms, Pzifer and Moderna. It is hardly a surprise that the mainstream media behave as if these are the only two vaccine options available in the world and give them preferential coverage.

However, equal to the progress these companies have made, a number of Chinese firms are also pacing forward with third stage clinical trials of a coronavirus vaccine.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

China , vaccine , covid-19 , covax , Tom Fowdy , CGTN

   

Next In Aseanplus News

CIIE unlocks China's growth opportunities for world
N. Korea fires salvo of short-range ballistic missiles ahead of US election
Money launderer Su Baolin’s former Sentosa Cove plot sold for S$22mil
Over 15% of Malaysian diaspora live in four countries, says HR Ministry
Ringgit opens higher as US$ weakens post-NFP data
Bursa Malaysia drifts sideways as investors await start of US election
More than 2,000 M'sians came home under Returning Expert Programme, says HR Ministry
Fundraising for Attorney General's retirement appreciation discontinued, says AGC
Packed schedule awaits Anwar on day two of working visit to Shanghai
Frenchman nabbed for drink-driving, hurling abuse at cops at Bayan Lepas roadblock

Others Also Read